- Home
- MRVI vs ASLE Comparison
MRVI vs ASLE Comparison
Compare MRVI & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- ASLE
- Stock Information
- Founded
- MRVI 2014
- ASLE 2008
- Country
- MRVI United States
- ASLE United States
- Employees
- MRVI N/A
- ASLE N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- ASLE Industrial Specialties
- Sector
- MRVI Health Care
- ASLE Consumer Discretionary
- Exchange
- MRVI Nasdaq
- ASLE Nasdaq
- Market Cap
- MRVI 376.2M
- ASLE 400.6M
- IPO Year
- MRVI 2020
- ASLE N/A
- Fundamental
- Price
- MRVI $2.81
- ASLE $8.33
- Analyst Decision
- MRVI Hold
- ASLE Hold
- Analyst Count
- MRVI 9
- ASLE 2
- Target Price
- MRVI $5.25
- ASLE $7.00
- AVG Volume (30 Days)
- MRVI 940.3K
- ASLE 480.3K
- Earning Date
- MRVI 11-06-2025
- ASLE 11-06-2025
- Dividend Yield
- MRVI N/A
- ASLE N/A
- EPS Growth
- MRVI N/A
- ASLE N/A
- EPS
- MRVI N/A
- ASLE 0.13
- Revenue
- MRVI $219,830,000.00
- ASLE $350,583,000.00
- Revenue This Year
- MRVI N/A
- ASLE $9.98
- Revenue Next Year
- MRVI $7.23
- ASLE $8.15
- P/E Ratio
- MRVI N/A
- ASLE $68.55
- Revenue Growth
- MRVI N/A
- ASLE N/A
- 52 Week Low
- MRVI $1.67
- ASLE $4.53
- 52 Week High
- MRVI $9.50
- ASLE $9.12
- Technical
- Relative Strength Index (RSI)
- MRVI 60.20
- ASLE 50.70
- Support Level
- MRVI $2.61
- ASLE $8.44
- Resistance Level
- MRVI $2.80
- ASLE $8.92
- Average True Range (ATR)
- MRVI 0.16
- ASLE 0.30
- MACD
- MRVI 0.04
- ASLE -0.09
- Stochastic Oscillator
- MRVI 76.09
- ASLE 22.08
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.